Prevalence and antifungal susceptibility patterns of dermatophytes isolated from patients with neoplastic diseases: a

Marius Irimie1, Alexandru Oanta, Claudia Alexandrina Irimie

  • 1Marius Irimie Irimie, MD, 40, Zizinului Street, Brasov, Romania; marius_irimie2002@yahoo.com.

Insights

Patients with cancer, especially hematologic malignancies, face a higher risk of fungal infections like dermatophytosis. Antifungal susceptibility remains similar to the general population, with terbinafine showing the most effectiveness.

Area of Science:

  • Mycology
  • Dermatology
  • Oncology

Background:

  • Severely immunocompromised patients with neoplasia are at increased risk for fungal infections.
  • Limited data exist on dermatophyte infection frequency and antifungal efficacy in cancer patients.

Purpose of the Study:

  • To assess the incidence of dermatophyte infections in cancer patients.
  • To determine antifungal susceptibility and identify dermatophyte species in this population.
  • To compare findings with immunocompetent individuals.

Main Methods:

  • Direct microscopy and Sabouraud agar cultures of nail/skin samples from 138 cancer patients and 160 controls.
  • In vitro antifungal susceptibility testing using broth microdilution.
  • Analysis of clinical presentation and species identification.

Main Results:

  • Dermatophyte infections occurred in 30.4% of cancer patients vs. 29.37% of controls.
  • Hematologic malignancy patients had a significantly higher infection rate (52%) than solid cancer patients (25.66%).
  • Terbinafine demonstrated the highest in vitro antifungal activity.

Conclusions:

  • Cancer patients, particularly those with hematologic malignancies, show a higher incidence of dermatophytosis.
  • Antifungal susceptibility patterns in cancer patients are comparable to immunocompetent individuals.
  • Clinical presentation may be more extensive in cancer patients, but terbinafine remains a key treatment option.

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
6.2K
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
64
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
727
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K